Recent research on Bifidobacterium lactis Bb-02 highlights several key areas:

1. Infants’ and Children's Health:

   • Bifidobacterium lactis is being evaluated for its role in mitigating early life dysbiosis, which is linked to conditions like asthma, allergies, obesity, and neurodevelopmental disorders. Clinical evidence suggests that B. lactis strains can help maintain a healthy microbiome in infants, potentially reducing the risk of these chronic diseases¹.

2. Oral Health:

   • Studies indicate that B. lactis Bb-02 may have beneficial effects on oral health. For instance, in a trial involving children, the consumption of Bifidobacterium animalis subsp. lactis BB-12 (a related strain) significantly reduced the prevalence of harmful oral bacteria such as mutans streptococci². Probiotic lozenges containing B. lactis also showed improvements in gingival health and a decrease in periodontal pathogens³.

3. Gut Health in Preterm Infants:

   • Research has shown that Bifidobacterium strains, including B. lactis, can prevent common gut-microbiota-associated complications in preterm infants. These probiotics help regulate cytokine levels, enhancing immune responses and potentially improving outcomes in preterm infants⁴.

These studies underscore the potential of Bifidobacterium lactis Bb-02 in diverse health areas, especially in early life stages and oral health maintenance.

Footnotes

1. Annie Tremblay, "Review and Perspectives on Bifidobacterium lactis for Infants’ and Children’s Health," PubMed Central, 2023. ↩

2. M.Y Jayachandra, "Clinical effects of Bifidobacterium as a probiotic on oral health: A systematic review," PubMed Central, 2023. ↩

3. M.Y Jayachandra, "Clinical effects of Bifidobacterium as a probiotic on oral health: A systematic review," PubMed Central, 2023. ↩

4. Fatemah Sadeghpour Heravi, "Bifidobacterium: Host–Microbiome Interaction and Mechanism of Action in Preventing Common Gut-Microbiota-Associated Complications in Preterm Infants: A Narrative Review," PubMed Central, 2023. ↩